Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Management of Melanoma Therapy-Associated Toxicities
Introduction There has been a dramatic shift in the treatment of advanced cutaneous melanoma within the last 5 years. Until 2011, the only FDA-approved therapies for metastatic melanoma were dacarbazine chemotherapy or high-dose interleukin-2 (IL-2) immunotherapy, which each have limited…